GlassScriptPhysician profile
Anil George
NPI 1154307684
$9,367.13
in general payments reported to CMS, 2019-2025
24 companies · $909 in 2025
The $909 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $169 · 2021: $187 · 2022: $2,651 · 2023: $2,975 · 2024: $2,026 · 2025: $909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $1,411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $1,411.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7,037.80 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $422.76 | 2022-2025 | Verquvo, Belsomra, Capvaxive |
| Novartis Pharmaceuticals Corporation | $383.54 | 2019-2025 | |
| Medtronic Vascular, INC. | $309.11 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $227.99 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $220.18 | 2021-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $120.62 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $117.34 | 2022-2025 | Aveir |
| Irhythm Technologies, INC. | $75.27 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $69.49 | 2023-2024 | |
| Amgen INC. | $68.72 | 2021-2024 | Repatha |
| Baxter Healthcare | $64.73 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $33.85 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $31.80 | 2022-2024 | Andexxa |
| Esperion Therapeutics, INC. | $28.92 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $27.01 | 2022 | |
| Arbor Pharmaceuticals, INC. | $23.55 | 2019 | |
| Vital Connect, INC | $20.59 | 2023 | Vitalpatch Rtm |
| Lilly USA, LLC | $15.51 | 2024 | Zepbound, Jardiance |
| Genzyme Corporation | $15.28 | 2019 | |
| Philips North America LLC | $13.72 | 2021 | |
| Amarin Pharma, INC. | $13.71 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $13.09 | 2023 | Inpefa |
| Glaxosmithkline, LLC. | $12.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.